181 related articles for article (PubMed ID: 16319499)
41. Development of real time imaging of specific messenger RNA in a living cell using artificial antisense nucleic acids.
Okabe K; Ikeda H; Harada Y; Funatsu T
Nucleic Acids Symp Ser (Oxf); 2005; (49):207-8. PubMed ID: 17150706
[TBL] [Abstract][Full Text] [Related]
42. Antisense inhibition of bacterial gene expression and cell growth.
Good L
Methods Mol Biol; 2002; 208():237-48. PubMed ID: 12229292
[No Abstract] [Full Text] [Related]
43. Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres.
Chiarantini L; Cerasi A; Millo E; Sparnacci K; Laus M; Riccio M; Santi S; Ballestri M; Spaccasassi S; Tondelli L
Int J Pharm; 2006 Oct; 324(1):83-91. PubMed ID: 16926075
[TBL] [Abstract][Full Text] [Related]
44. Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics.
Popella L; Jung J; Popova K; Ðurica-Mitić S; Barquist L; Vogel J
Nucleic Acids Res; 2021 May; 49(8):4705-4724. PubMed ID: 33849070
[TBL] [Abstract][Full Text] [Related]
45. Design and off-target prediction for antisense oligomers targeting bacterial mRNAs with the MASON web server.
Jung J; Popella L; Do PT; Pfau P; Vogel J; Barquist L
RNA; 2023 May; 29(5):570-583. PubMed ID: 36750372
[TBL] [Abstract][Full Text] [Related]
46. Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA).
Robaczewska M; Narayan R; Seigneres B; Schorr O; Thermet A; Podhajska AJ; Trepo C; Zoulim F; Nielsen PE; Cova L
J Hepatol; 2005 Feb; 42(2):180-7. PubMed ID: 15664242
[TBL] [Abstract][Full Text] [Related]
47. Recent Advances in Peptide Nucleic Acids as Antibacterial Agents.
Chen W; Dong B; Liu W; Liu Z
Curr Med Chem; 2021; 28(6):1104-1125. PubMed ID: 32484766
[TBL] [Abstract][Full Text] [Related]
48. Recognition of chromosomal DNA by PNAs.
Kaihatsu K; Janowski BA; Corey DR
Chem Biol; 2004 Jun; 11(6):749-58. PubMed ID: 15217608
[TBL] [Abstract][Full Text] [Related]
49. Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect.
Nikravesh A; Dryselius R; Faridani OR; Goh S; Sadeghizadeh M; Behmanesh M; Ganyu A; Klok EJ; Zain R; Good L
Mol Ther; 2007 Aug; 15(8):1537-42. PubMed ID: 17534267
[TBL] [Abstract][Full Text] [Related]
50. Peptide nucleic acids as antibacterial agents via the antisense principle.
Nielsen PE
Expert Opin Investig Drugs; 2001 Feb; 10(2):331-41. PubMed ID: 11178345
[TBL] [Abstract][Full Text] [Related]
51. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
Tan XX; Actor JK; Chen Y
Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive analysis of PNA-based antisense antibiotics targeting various essential genes in uropathogenic Escherichia coli.
Popella L; Jung J; Do PT; Hayward RJ; Barquist L; Vogel J
Nucleic Acids Res; 2022 Jun; 50(11):6435-6452. PubMed ID: 35687096
[TBL] [Abstract][Full Text] [Related]
53. Comparison of novel delivery systems for antisense peptide nucleic acids.
Chiarantini L; Cerasi A; Fraternale A; Millo E; Benatti U; Sparnacci K; Laus M; Ballestri M; Tondelli L
J Control Release; 2005 Dec; 109(1-3):24-36. PubMed ID: 16290244
[TBL] [Abstract][Full Text] [Related]
54. [PNA--peptide nuclei acids. Used as gene-therapeutic drugs].
Nielsen PE
Nord Med; 1998 Oct; 113(8):268-71. PubMed ID: 9801471
[TBL] [Abstract][Full Text] [Related]
55. Getting sense and finding function in protozoa.
Ramakrishnan G; Petri W
Nat Biotechnol; 2001 Mar; 19(3):213-5. PubMed ID: 11231546
[No Abstract] [Full Text] [Related]
56. Defining the peptide nucleic acids (PNA) length requirement for PNA binding-induced transcription and gene expression.
Wang G; Jing K; Balczon R; Xu X
J Mol Biol; 2001 Nov; 313(5):933-40. PubMed ID: 11700050
[TBL] [Abstract][Full Text] [Related]
57. Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.
Kilk K; Elmquist A; Saar K; Pooga M; Land T; Bartfai T; Soomets U; Langel U
Neuropeptides; 2004 Oct; 38(5):316-24. PubMed ID: 15464198
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial Activity of Peptide-Coupled Antisense Peptide Nucleic Acids in Streptococcus pneumoniae.
Barkowsky G; Abt C; Pöhner I; Bieda A; Hammerschmidt S; Jacob A; Kreikemeyer B; Patenge N
Microbiol Spectr; 2022 Dec; 10(6):e0049722. PubMed ID: 36321914
[TBL] [Abstract][Full Text] [Related]
59. Method of Peptide Nucleic Acid (PNA)-Mediated Antisense Inhibition of Gene Expression in Campylobacter jejuni.
Oh E; Jeon B
Methods Mol Biol; 2017; 1512():43-49. PubMed ID: 27885597
[TBL] [Abstract][Full Text] [Related]
60. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
